Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 194 publications
Establishment of 68Ga-DOTA-Based Pretargeted Radioimmunodiagnosis.
Journal: Molecular pharmaceutics
Published: May 19, 2026
Pretargeted 177Lu/225Ac combination therapy of colorectal cancer.
Journal: Theranostics
Published: October 08, 2025
A phase II trial of naxitamab plus stepped-up dosing of GM-CSF for patients with high-risk neuroblastoma in second or later complete remission.
Journal: International journal of cancer
Published: October 03, 2025
Naxitamab plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for primary refractory high-risk neuroblastoma: results of a phase I/II trial.
Journal: Journal of hematology & oncology
Published: September 22, 2025
Author Correction: Clonal evolution during metastatic spread in high-risk neuroblastoma.
Journal: Nature genetics
Published: August 06, 2025
Local Control With Reduced-Dose Radiation Therapy for High-Risk Neuroblastoma: Results From a Prospective Clinical Trial.
Journal: International journal of radiation oncology, biology, physics
Published: August 01, 2025
Paediatric Strategy Forum for medicinal product development of agents targeting GD2 ganglioside in children and adolescents with cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 29, 2025
T cell-engaging bispecific antibodies for myeloid malignancies: Targets, formats, and clinical challenges.
Journal: Cell reports. Medicine
Published: July 15, 2025
Preclinical 203/212Pb-DOTA-Based Pretargeted Radioimmunotherapy in Nude Mice Bearing Established Human Colorectal Cancer Xenografts.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 12, 2025
Phase 1 dose-escalation trial using convection-enhanced delivery of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma.
Journal: Neuro-oncology
Published: February 19, 2025
Last Updated: 09/26/2026